News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
AcelRx Pharmaceuticals Prices IPO
January 24, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Xconomy -- Redwood City, CA-based AcelRx Pharmaceuticals, which filed paperwork last November for an initial public offering on the Nasdaq exchange, set its IPO terms in an updated regulatory filing yesterday.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
IPO
Biotech Finally Has an IPO After Months-Long Freeze
August 25, 2025
·
1 min read
·
Annalee Armstrong
Acquisitions
Unswayed by Cerevel Failure, AbbVie Buys Gilgamesh’s Depression Drug for $1.2B
August 25, 2025
·
3 min read
·
Annalee Armstrong
GLP-1
Novo Teams Up With GoodRx for Lower-Price GLP-1s, Giving DTC Another Shot
August 18, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
Tang Capital’s Concentra on Buyout Binge With Plenty of Biotech Fodder
August 13, 2025
·
4 min read
·
Annalee Armstrong